PARPBP
PCNA-interacting partner
Also known as: C12orf48, FLJ20641, PARI, PARI_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NWS1
- Gene
- PARPBP
- Ensembl
- ENSG00000185480
- Chromosome
- 12
- Canonical length
- 579 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA binding activity. Involved in negative regulation of double-strand break repair via homologous recombination. Located in chromatin and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
579 residues, UniProt reviewed canonical sequence.
>Q9NWS1|PARPBP
1 MAVFNQKSVS DMIKEFRKNW RALCNSERTT LCGADSMLLA LQLSMAENNK QHSGEFTVSL
61 SDVLLTWKYL LHEKLNLPVE NMDVTDHYED VRKIYDDFLK NSNMLDLIDV YQKCRALTSN
121 CENYNTVSPS QLLDFLSGKQ YAVGDETDLS IPTSPTSKYN RDNEKVQLLA RKIIFSYLNL
181 LVNSKNDLAV AYILNIPDRG LGREAFTDLK HAAREKQMSI FLVATSFIRT IELGGKGYAP
241 PPSDPLRTHV KGLSNFINFI DKLDEILGEI PNPSIAGGQI LSVIKMQLIK GQNSRDPFCK
301 AIEEVAQDLD LRIKNIINSQ EGVVALSTTD ISPARPKSHA INHGTAYCGR DTVKALLVLL
361 DEEAANAPTK NKAELLYDEE NTIHHHGTSI LTLFRSPTQV NNSIKPLRER ICVSMQEKKI
421 KMKQTLIRSQ FACTYKDDYM ISKDNWNNVN LASKPLCVLY MENDLSEGVN PSVGRSTIGT
481 SFGNVHLDRS KNEKVSRKST SQTGNKSSKR KQVDLDGENI LCDNRNEPPQ HKNAKIPKKS
541 NDSQNRLYGK LAKVAKSNKC TAKDKLISGQ AKLTQFFRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARPBP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 8.8 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 8.8 nTPM
- thymus: 7 nTPM
- tonsil: 4.8 nTPM
- lymph node: 3.9 nTPM
- testis: 3.7 nTPM
- rectum: 3.6 nTPM
Single-cell type
- erythrocyte progenitors: 116 nCPM
- monocyte progenitors: 101 nCPM
- megakaryocyte progenitors: 80 nCPM
- neutrophil progenitors: 72 nCPM
- differentiating spermatogonia: 54 nCPM
- enteric transient amplifying cells: 40 nCPM
Immune cell
- basophil: 2.6 nTPM
- T-reg: 1.8 nTPM
- memory B-cell: 1.1 nTPM
- eosinophil: 1 nTPM
- memory CD4 T-cell: 0.9 nTPM
- memory CD8 T-cell: 0.8 nTPM
Brain region
- hypothalamus: 1.1 nTPM
- pons: 1.1 nTPM
- cerebellum: 0.9 nTPM
- cerebral cortex: 0.9 nTPM
- spinal cord: 0.9 nTPM
- medulla oblongata: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.33
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-loop containing nucleoside triphosphate hydrolase
- PCNA-interacting partner
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARPBP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARPBP as an antibody target. Whether an autoantibody or antibody against PARPBP could matter depends on whether native PARPBP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARPBP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARPBP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...